These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 11303591
1. Urinary phytoestrogens and postmenopausal breast cancer risk. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH. Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591 [Abstract] [Full Text] [Related]
2. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W. Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):815-21. PubMed ID: 12223424 [Abstract] [Full Text] [Related]
4. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Piller R, Chang-Claude J, Linseisen J. Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865 [Abstract] [Full Text] [Related]
6. Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Horn-Ross PL, Hoggatt KJ, Lee MM. Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):43-9. PubMed ID: 11815400 [Abstract] [Full Text] [Related]
10. Urinary phytoestrogens and risk of prostate cancer in Jamaican men. Jackson MD, McFarlane-Anderson ND, Simon GA, Bennett FI, Walker SP. Cancer Causes Control; 2010 Dec; 21(12):2249-57. PubMed ID: 20924663 [Abstract] [Full Text] [Related]
14. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738 [Abstract] [Full Text] [Related]
16. Case-control study of phyto-oestrogens and breast cancer. Ingram D, Sanders K, Kolybaba M, Lopez D. Lancet; 1997 Oct 04; 350(9083):990-4. PubMed ID: 9329514 [Abstract] [Full Text] [Related]
17. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada). Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU. Cancer Causes Control; 2008 Apr 04; 19(3):259-72. PubMed ID: 17992574 [Abstract] [Full Text] [Related]
18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE. J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882 [Abstract] [Full Text] [Related]
19. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study. Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, Landberg G, Wirfält E. Cancer Epidemiol Biomarkers Prev; 2008 Nov 20; 17(11):3241-51. PubMed ID: 18990767 [Abstract] [Full Text] [Related]
20. Urinary estrogen metabolites and breast cancer: a case-control study. Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL. Cancer Epidemiol Biomarkers Prev; 1997 Jul 20; 6(7):505-9. PubMed ID: 9232337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]